BSE filing, NSE: SANOFI. Summary written from the filing by ALFA Finder's alert engine.
Sanofi India Ltd: key numbers
- Share price
- ₹2,992.00
- Market cap
- ₹6,891 Cr
- Revenue (annual)
- ₹1,837 Cr
- Net profit (annual)
- ₹326.7 Cr
- P/E (TTM)
- 21.3×Sector 46.1×
- Promoter holding
- 60.40%+0.00% QoQ
- FII holding
- 5.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi India Ltd
All →Sanofi India Board Meeting Date
Sanofi India will hold a board meeting on 29th October 2026 to consider unaudited financial results and a potential interim dividend for FY 2026.
Sanofi India Promoter Buying (Off-Market): ₹1,068 Cr
Sanofi Healthcare India acquired 3.5 million shares (15.20%) from Hoechst GmbH in a promoter-group block deal at ₹3,052/share. Total promoter stake unchanged at 60.40%.
- Value
- ₹1,068 Cr
- Promoter stake change
- +15.20%
Sanofi India Legal & Regulatory
Sanofi India received a GST show cause notice from Ahmedabad authorities for FY 2022-23. The notice proposes a tax, interest, and penalty demand totaling Rs.16.40 Crore.
- Value
- ₹16.40 Cr
Sanofi India Promoter Selling (Off-Market): ₹1,068 Cr
Sanofi India promoter Hoechst GmbH sold 35,00,000 equity shares for ₹1,068.20 Crore. The transaction was an inter-se transfer via block deal, reducing its stake to 45.18%.
- Value
- ₹1,068 Cr
Sanofi India Promoter Buying (Off-Market): ₹1,068 Cr
Sanofi Healthcare India, a promoter group entity, acquired 35,00,000 shares (15.20%) of Sanofi India Ltd for ₹1,068.20 Crore. The transaction was an inter-se transfer via block deal.
- Value
- ₹1,068 Cr
- Promoter stake change
- +15.20%
Sanofi India Legal & Regulatory
Sanofi India received a GST show cause notice alleging excess input tax credit claims. The total demand, including interest, is Rs. 23.74 Crore.
- Value
- ₹23.74 Cr
- From
- Commercial Tax Officer (Audit)-6.1, DGSTO-6, Bengaluru
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.